44 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MDT Medtronic plc $96.03 $129.69B N/A
Article Searches
Medtronic Displays All-Business-Line Growth Despite Cost Woes http://www.zacks.com/stock/news/646621/medtronic-displays-all-business-line-growth-despite-cost-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-646621 Nov 29, 2019 - Medtronic's (MDT) Diabetes group is expanding internationally on the strong rollout of its MiniMed 670G in untapped markets.
3 Dividend-Growth Stocks That Are Paying Investors Up to 5.1% https://www.fool.com/investing/2019/12/16/3-dividend-growth-stocks-that-are-paying-investors.aspx?source=iedfolrf0000001 Dec 16, 2019 - These stocks offer investors a mix of stability, growth, and value.
Here's Why You Should Hold on to Globus Medical Stock for Now http://www.zacks.com/stock/news/678223/heres-why-you-should-hold-on-to-globus-medical-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-678223 Dec 19, 2019 - Investors continue to be optimistic about Globus Medical (GMED) on its stellar segmental performance.
6 MedTech Stocks That are Set to Beat the Market in 2020 http://www.zacks.com/stock/news/685692/6-medtech-stocks-that-are-set-to-beat-the-market-in-2020?cid=CS-ZC-FT-analyst_blog|investment_ideas-685692 Dec 24, 2019 - Banking on the three key trends, we zero in on six MedTech stocks that are likely to deliver stellar performance in 2020.
Here's Why You Should Buy Align Technology (ALGN) Stock Now http://www.zacks.com/stock/news/704618/heres-why-you-should-buy-align-technology-algn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-704618 Jan 06, 2020 - Investors continue to be optimistic about Align Technology (ALGN) on its stellar segmental performance in Q3.
Abbott's Less-Invasive Surgery for Heart Pump Gets FDA Nod http://www.zacks.com/stock/news/708050/abbotts-less-invasive-surgery-for-heart-pump-gets-fda-nod?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-708050 Jan 08, 2020 - Abbott's (ABT) less invasive approach for heart surgery for its heart pump gets the FDA clearance, thus paving the way for avoiding open heart surgeries.
Medtronic (MDT) Buys Stimgenics, To Present New Trial Results http://www.zacks.com/stock/news/709477/medtronic-mdt-buys-stimgenics-to-present-new-trial-results?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-709477 Jan 09, 2020 - Medtronic (MDT) acquires Stimgenics to integrate DTM therapy in its pain therapies segment. It will also present trial results favoring the therapy at the upcoming NANS meeting.
UnitedHealth (UNH) to Post Q4 Earnings: What's in the Cards? http://www.zacks.com/stock/news/715487/unitedhealth-unh-to-post-q4-earnings-whats-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-715487 Jan 13, 2020 - UnitedHealth's (UNH) Q4 earnings are likely to have benefited from its operating segments and membership growth.
Medtronic plc. (MDT) CEO Omar Ishrak Presents at the 38th Annual J.P. Morgan Healthcare Conference - Transcript https://seekingalpha.com/article/4316552-medtronic-plc-mdt-ceo-omar-ishrak-presents-38th-annual-j-p-morgan-healthcare-conference?source=feed_sector_transcripts Jan 13, 2020 - Medtronic plc. (NYSE:MDT) 38th Annual J.P. Morgan Healthcare Conference January 13, 2020, 12:30 PM ET Company Participants Omar Ishrak - Chairman and CEO Conference Call Participants Robert Marcus - J
Medtronic (MDT) Hits 52-Week High, Can the Run Continue? http://www.zacks.com/stock/news/726453/medtronic-mdt-hits-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-726453 Jan 20, 2020 - Medtronic (MDT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Pages: 12345

Page 1>